Robuta

https://stanfordhealthcare.org/publications/481/481750.html 481750 | Stanford Health Care Randomized, dose-escalation study of the p38 alpha MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome stanfordhealthcare